InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: investor_61 post# 39760

Monday, 08/15/2016 12:14:56 PM

Monday, August 15, 2016 12:14:56 PM

Post# of 42929
and if Manzo performs a fantasy miracle

and does end up with product, how much of a "cut" do Jay Sharma and Celprogen get?



Technically MNZO is the assigned patent holder of a worthless patent. No details were ever given per the patent assignment. All that is known is Kenny got some MNZO stock for having arranged it.

In the real world, if there was any possibility of marketing such a product, Kenny&Sharma would've tried for private equity funding, with the patent assigned to Celpro. Ran Phase 1-2 trials, assuming the FDA would even approve such trials. Then put up the For Sale sign soliciting a big Pharma buyer for Celpro. And/or an IPO on the big board soliciting a Pharma partner.

Instead in the fantasy Microcrap world, Kenny&Sharma play games with MDIN, and footsie with the likes of Barton in MNZO. Objective: To fleece retail so called "investors", with imaginary products, and P&Ds. Now that's on hold with the SEC after Kenny.

The Jewel of the Mind is Colored with the Hue of what it Imagines